Entity Index
2 direct matches across person references, story text, source records, and indexed tags.
These editor-confirmed paths connect a public entity mention in original reporting to a published follow-up. A link is not a truth verdict.
%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M0%20706%20L1536%20432%20L1536%201024%20L0%201024%20Z%22%20fill%3D%22%23f7d56b%22%20opacity%3D%220.18%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M1060%200%20L1536%200%20L1536%201024%20L1250%201024%20Z%22%20fill%3D%22%23d01f2f%22%20opacity%3D%220.38%22%2F%3E%0A%20%20%3Crect%20x%3D%2284%22%20y%3D%2288%22%20width%3D%22210%22%20height%3D%2218%22%20fill%3D%22%23d01f2f%22%2F%3E%0A%20%20%3Ctext%20x%3D%2284%22%20y%3D%22164%22%20fill%3D%22%23ffffff%22%20font-family%3D%22Arial%2C%20Helvetica%2C%20sans-serif%22%20font-size%3D%2264%22%20font-weight%3D%22900%22%3EWORLD%3C%2Ftext%3E%0A%3C%2Fsvg%3E)
South China Morning Post World
Mainland Chinese institutional investors are increasing their holdings in Hong Kong-listed biotechnology firms, attracted by favorable valuations and a rise in cross-border licensing agreements.
Showing 1-2 of 2 articles.
%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M0%20706%20L1536%20432%20L1536%201024%20L0%201024%20Z%22%20fill%3D%22%23f3f5f7%22%20opacity%3D%220.18%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M1060%200%20L1536%200%20L1536%201024%20L1250%201024%20Z%22%20fill%3D%22%23cc0000%22%20opacity%3D%220.38%22%2F%3E%0A%20%20%3Crect%20x%3D%2284%22%20y%3D%2288%22%20width%3D%22210%22%20height%3D%2218%22%20fill%3D%22%23cc0000%22%2F%3E%0A%20%20%3Ctext%20x%3D%2284%22%20y%3D%22164%22%20fill%3D%22%23ffffff%22%20font-family%3D%22Arial%2C%20Helvetica%2C%20sans-serif%22%20font-size%3D%2264%22%20font-weight%3D%22900%22%3EWORLD%3C%2Ftext%3E%0A%3C%2Fsvg%3E)
world
For the first time, a mainland Chinese court has taken jurisdiction over a lawsuit involving a Hong Kong-listed firm, signaling increased scrutiny on corporate disclosures amid growing mainland investment in Hong Kong markets.
South China Morning Post World | Jul 8, 2026, 4:14 AMShowing 1-2 of 2 articles.